Urinary butadiene diepoxide: a potential biomarker of blood diepoxide

The carcinogenicity of 1,3-butadiene (BD) varies greatly in the rodent species in which 2-year bioassay studies were completed. This raises the question of whether the risk of BD exposure in humans is more like that of the sensitive species, the mouse, or more like that of the resistant species, the...

Full description

Saved in:
Bibliographic Details
Published in:Toxicology (Amsterdam) 2001-03, Vol.160 (1), p.81-86
Main Authors: Henderson, Rogene F., Bechtold, William E., Thornton-Manning, Janice R., Dahl, Alan R.
Format: Article
Language:English
Subjects:
1,3-Butadiene
Animals
Biological and medical sciences
Biomarkers
Biomarkers - urine
Butadiene diepoxide
Butadienes - pharmacokinetics
Carcinogenesis, carcinogens and anticarcinogens
Carcinogenicity
Carcinogens - pharmacokinetics
Chemical agents
Chemical and industrial products toxicology. Toxic occupational diseases
diepoxides
Epoxy Compounds - blood
Epoxy Compounds - urine
erythritol anhydride
Gas Chromatography-Mass Spectrometry
Male
Medical sciences
Mice
Mice, Inbred Strains
Rats
Rats, Sprague-Dawley
Species Specificity
Toxicology
Tumors
Various organic compounds
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The carcinogenicity of 1,3-butadiene (BD) varies greatly in the rodent species in which 2-year bioassay studies were completed. This raises the question of whether the risk of BD exposure in humans is more like that of the sensitive species, the mouse, or more like that of the resistant species, the rat. Numerous studies have indicated that one reason for the species differences in response to BD is that the blood and tissues of BD-exposed mice contain high levels of both the mono- and the diepoxide metabolite, while the tissue and blood of exposed rats contain very little of the diepoxide. The diepoxide is far more mutagenic than the monoepoxide, and so it is reasonable that the diepoxide plays a major role in tumor induction in the mouse. If the diepoxide is the primary carcinogen, the presence of the diepoxide in the blood of exposed individuals should be an indicator of risk from BD exposure. In this study, we report that the diepoxide is sufficiently stable to be excreted into the urine of exposed rodents and that the urinary levels of the diepoxide reflect the relative levels of the compound in the blood of the two species. The conclusion is that urinary diepoxide should be investigated as a potential biomarker of the formation of the diepoxide in humans exposed to BD.
ISSN:0300-483X
1879-3185
DOI:10.1016/S0300-483X(00)00438-8